Study Of Investigational Agent Abiraterone Acetate For Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria
Links shared publicly online about this topic.
- 884total visits
Study Of Investigational Agent Abiraterone Acetate For Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria
View full resource at medicalnewstoday.com
Tags: Cancer, Prostate Cancer, Prostate, Phase 3 Clinical Trial, Biotech, Men's Health, Prednisone, Oncology
Most Recently Shared on September 10, 2010 at 7:00 pm By:
Study Of Investigational Agent Abiraterone Acetate For Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre... http://mnt.to/3JyF
Also Shared By:
Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria - Drugs.com MedNews
drugs.com — “Ortho Biotech Oncology Research Development, a unit of Cougar Biotechnology, Inc., today announced that it has unblinded the Phase 3 study of abiraterone acetat” View full resource at drugs.com
Most Recently Shared on September 12, 2010 at 11:15 pm By:
Drugs and Devices OW OW Health
Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded After Me... http://bit.ly/aJmLgm #drug
Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded After... -- LOS ANGELES, Sept. 9 /PRNewswire/ --
prnewswire.com — “Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria.” View full resource at prnewswire.com
Most Recently Shared on September 10, 2010 at 9:47 pm By:
Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced ... http://bit.ly/949cWw
Advertisement
MNT Pharma News
@mnt_pharma
Study Of Investigational Agent Abiraterone Acetate For Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre... http://mnt.to/3JyF
1 year ago...